乌干达与赞比亚儿童疫苗接种覆盖率的决定因素与障碍
研究利用乌干达和赞比亚家庭、卫生机构、患者及卫生办公室的关联横断面调查数据,采用贝叶斯结构方程模型量化关键决定因素对儿童疫苗接种差异的解释比例。结果显示不同疫苗结局的主要决定因素不同:三剂五价疫苗以母亲接种意愿为主导,一剂疫苗以社区可及性为主要因素,肺炎球菌结合疫苗以卫生机构准备度为主导。作者认为未来研究应改进分析框架并在不同场景应用。
要点
- 三剂五价疫苗覆盖的主导决定因素是母亲接种意愿。
- 一剂五价疫苗覆盖的主导决定因素是社区可及性。
- 肺炎球菌结合疫苗覆盖的主导决定因素是卫生机构准备度。
核心结论
- 疫苗接种的决定因素应结合具体疫苗结局来考量,不同结局的主导决定因素不同。
- 模型提示改善费用、机构服务人口和人员配置预计可带来最大的覆盖率提升。
- 未来研究应改进分析框架、在不同场景应用并采用更强的研究设计。
研究设计与样本
- 研究使用乌干达和赞比亚家庭、卫生机构、患者及卫生办公室的关联横断面调查数据。
- 采用贝叶斯结构方程模型量化关键决定因素解释的儿童疫苗接种差异比例,并控制已知混杂。
主要发现
- 三剂五价疫苗:母亲接种意愿是主导驱动因素。
- 一剂五价疫苗:社区可及性是较大因素。
- 肺炎球菌结合疫苗:卫生机构准备度是主导驱动因素。
- 按模型,改善费用、机构服务人口和人员配置预计带来覆盖率最大提升。
临床怎么用
- 作者认为在这些国家,疫苗接种项目应利用本研究发现更好地靶向干预并持续推进疫苗可预防疾病的防控。
- 作者认为聚焦某一决定因素的项目应利用这些结果选择适合衡量其效果的评价结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Improving childhood vaccine coverage is a priority for global health, but challenging in low and middle-income countries. Although previous research has sought to measure determinants of vaccination, most has limitations. We measure determinants using a clearly-defined hypothetical model, multi-faceted data, and modeling strategy that makes full use of the hypothesis and data. METHODS: We use linked, cross-sectional survey data from households, health facilities, patients and health offices in Uganda and Zambia, and Bayesian Structural Equation Modeling to quantify the proportion of variance in childhood vaccination that is explained by key determinants, controlling for known confounding. RESULTS: We find evidence that the leading determinant of vaccination is different for different outcomes. For three doses of pentavalent vaccine, intent to vaccinate (on the part of the mother) is the leading driver, but for one dose of the vaccine, community access is a larger factor. For pneumococcal conjugate vaccine, health facility readiness is the leading driver. Considering specifically-modifiable determinants, improvements in cost, facility catchment populations and staffing would be expected to lead to the largest increase in coverage according to the model. CONCLUSIONS: This analysis measures vaccination determinants using improved methods over most existing research. It provides evidence that determinants should be approached in the context of relevant outcomes, and evidence of specific determinants that could have the greatest impact in these two countries, if targeted. Future studies should seek to improve our analytic framework, apply it in different settings, and utilize stronger study designs. Programs that focus on a particular determinant should use these results to select an outcome that is appropriate to measure their effectiveness. Vaccination programs in these countries should use our findings to better target interventions and continue progress against vaccine preventable diseases.
引用
- Phillips DE, Dieleman JL, Shearer JC, et al. Childhood vaccines in Uganda and Zambia: Determinants and barriers to vaccine coverage. Vaccine. 2018. PMID: 29885772. doi:10.1016/j.vaccine.2018.05.116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。